Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study

This open-label, multinational, pilot study randomized (1:2 ratio) adults with HIV-1 RNA <40 copies per milliliter and nucleos(t)ide-related safety/tolerability issues to switch to ritonavir-boosted atazanavir (ATV/r) plus tenofovir disoproxil fumarate/emtricitabine (n = 37) or the nucleos(t)ide...

Descripción completa

Detalles Bibliográficos
Autores principales: van Lunzen, Jan, Pozniak, Anton, Gatell, Jose M., Antinori, Andrea, Klauck, Isabelle, Serrano, Oscar, Baakili, Adyb, Osiyemi, Olayemi, Sevinsky, Heather, Girard, Pierre-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804741/
https://www.ncbi.nlm.nih.gov/pubmed/26605505
http://dx.doi.org/10.1097/QAI.0000000000000904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804741/
https://www.ncbi.nlm.nih.gov/pubmed/26605505
http://dx.doi.org/10.1097/QAI.0000000000000904

Ejemplares similares